Market Research Logo

United States Neurosurgical Products Market Outlook to 2025

United States Neurosurgical Products Market Outlook to 2025

Summary

GlobalData’s new report, United States Neurosurgical Products Market Outlook to 2025, provides key market data on the United States Neurosurgical Products market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Dura Substitutes, Neuroendoscopes and Neurosurgical Drills.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Neurosurgical Products market segments - Dura Substitutes, Neuroendoscopes and Neurosurgical Drills.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Neurosurgical Products market.
  • Global corporate-level profiles of key companies operating within the United States Neurosurgical Products market.
  • Key players covered include B. Braun Melsungen AG, Integra LifeSciences Corp, Medtronic plc, Stryker Corp and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Neurosurgical Products Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Neurosurgical Products Market, United States 8
3.1 Neurosurgical Products Market, United States, Revenue ($m), 2015-2025 8
3.1.1 Dura Substitutes Market, United States, Revenue ($m), by Segment, 2015-2025 10
3.1.2 Neuroendoscopes Market, United States, Revenue ($m), by Segment, 2015-2025 12
3.1.3 Neurosurgical Drills Market, United States, Revenue ($m), by Segment, 2015-2025 14
3.2 Neurosurgical Products Market, United States, Volume (Units), 2015-2025 16
3.2.1 Dura Substitutes Market, United States, Volume (Units), by Segment, 2015-2025 18
3.2.2 Neuroendoscopes Market, United States, Volume (Units), by Segment, 2015-2025 20
3.2.3 Neurosurgical Drills Market, United States, Volume (Units), by Segment, 2015-2025 22
3.3 Neurosurgical Products Market, United States, Average Price ($), 2015-2025 24
3.4 Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), 2017 26
3.5 Neurosurgical Products Market, United States, Company Share by Revenue ($m), 2017 27
4 Overview of Key Companies in United States, Neurosurgical Products Market 29
4.1 B. Braun Melsungen AG 29
4.1.1 Company Overview 29
4.2 Medtronic Plc 29
4.2.1 Company Overview 29
4.3 Stryker Corp 29
4.3.1 Company Overview 29
4.4 KARL STORZ GmbH & Co KG 30
4.4.1 Company Overview 30
4.5 DePuy Synthes Inc 30
4.5.1 Company Overview 30
4.6 Baxter International Inc 30
4.6.1 Company Overview 30
4.7 Integra LifeSciences Corp 30
4.7.1 Company Overview 30
5 Neurosurgical Products Market Pipeline Products 31
6 Financial Deals Landscape 32
6.1 Debt Offerings 32
6.1.1 Stryker Raises USD600 Million in Public Offering of 3.65% Notes Due 2028 32
6.2 Equity Offerings 34
6.2.1 Integra LifeSciences Prices Public Offering of Shares for USD307 Million 34
6.3 Partnerships 36
6.3.1 MRI Interventions Enters into Strategic Agreement with Voyager Therapeutics 36
6.4 Private Equity 37
6.4.1 Shanghai Xianfeng Investment Management to Acquire Elliquence from Alan Ellman for USD77.1 Million 37
6.4.2 Sobera Capital Acquires Equity Holdings in 12 Pharma Companies 38
6.4.3 NeuroPace Raises USD74 Million in Equity Financing 40
6.5 Venture Financing 41
6.5.1 Myoscience Raises USD10 Million in Financing 41
6.5.2 Alcyone Lifesciences Raises USD5 Million in Venture Financing 43
6.5.3 MicroTransponder Raises USD11.6 Million in Venture Financing 44
7 Recent Developments 45
7.1 Corporate Communications 45
7.1.1 Jul 10, 2018: Stryker announces organizational changes 45
7.1.2 May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility 45
7.1.3 Feb 19, 2018: FHC Promotes Melanie Cooper To Director Of Resources 45
7.1.4 Feb 07, 2018: Cardinal Health Adds Akhil Johri to its Board of Directors 46
7.1.5 Jan 09, 2018: Kelyniam Global Announces Key Management Changes 46
7.1.6 Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors 47
7.1.7 Nov 22, 2017: IMRIS Appoints Mark Strong as Senior Vice President - Research & Development 47
7.1.8 Nov 06, 2017: Cardinal Health Outlines Leadership Succession Plan 47
7.2 Financial Announcements 50
7.2.1 Jul 18, 2018: Precipio announces 213% year-over-year revenue growth in preliminary Q2-2018 results 50
7.2.2 May 15, 2018: MRI Interventions Announces First Quarter 2018 Results 50
7.2.3 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018 52
7.2.4 May 03, 2018: RTI Surgical Announces First Quarter 2018 Results 53
7.2.5 Apr 26, 2018: Stryker reports first quarter 2018 operating results 54
7.2.6 Mar 30, 2018: Vycor Medical Announces Financial Results for the Year Ended December 31st, 2017 55
7.2.7 Mar 15, 2018: MRI Interventions Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales 56
7.2.8 Mar 01, 2018: RTI Surgical Announces Fourth Quarter and Full Year 2017 Results 58
7.2.9 Feb 27, 2018: Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results 59
7.2.10 Feb 08, 2018: Cardinal Health Reports Second-quarter Results for Fiscal Year 2018 61
7.2.11 Feb 06, 2018: MRI Interventions Announces Record 629 ClearPoint Cases in 2017 62
7.2.12 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook 63
7.2.13 Jan 09, 2018: Stryker provides 2017 preliminary net sales results 64
7.2.14 Jan 08, 2018: Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Result 65
7.2.15 Nov 13, 2017: Vycor Medical Reports Financial Results for the Three and Nine Months Ended September 30th, 2017 65
7.2.16 Nov 06, 2017: MRI Interventions Reports 26% Year-Over-Year Increase in Third Quarter Procedures 66
7.2.17 Nov 06, 2017: Cardinal Health Reports First-quarter Results for Fiscal Year 2018 69
7.2.18 Nov 02, 2017: RTI Surgical Announces 2017 Third Quarter Results 70
7.2.19 Oct 26, 2017: Stryker reports third quarter 2017 results 71
7.2.20 Oct 26, 2017: Integra LifeSciences Reports Third Quarter 2017 Financial Results 72
7.3 Government and Public Interest 73
7.3.1 Apr 03, 2018: Important JAMA Article Underscores Superiority of Precipio’s Liquid Biopsy Core Technology 73
7.4 Legal And Regulatory 74
7.4.1 Mar 13, 2018: Precipio Settles Lawsuit with Crede Capital 74
7.5 Other Significant Developments 75
7.5.1 Jun 19, 2018: Cardinal Health Foundation Awards Over $3 Million to More Than 70 Nonprofit Organizations to Fight the Opioid Epidemic across Appalachia 75
7.5.2 Jun 12, 2018: IMRIS Continues to Expand Global Customer Service 76
7.5.3 Apr 04, 2018: RTI Surgical Reaches Global Milestone of Providing 8 Million Biologic Implants with Zero Confirmed Incidence of Implant-Associated Infection 77
7.5.4 Feb 22, 2018: Kelyniam Global Announces Multi-year Distribution Partnership 77
7.5.5 Feb 08, 2018: IMRIS Reports Continued Strong Growth in 2017 78
7.5.6 Jan 05, 2018: RTI Surgical Outlines 2018 Guidance and Long-Term Goals 78
7.6 Product News 79
7.6.1 Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 79
7.6.2 Apr 26, 2018: Integra LifeSciences Debuts Codman Specialty Surgical Extended Portfolio At AANS 2018 79
8 Appendix 81
8.1 Research Methodology 82
8.1.1 Coverage 82
8.1.2 Secondary Research 82
8.1.3 Primary Research 83
8.1.4 Market Modeling and Forecasting 84
8.1.5 Company Share Analysis 85
8.1.6 Distribution Share Analysis 86
8.1.7 Benchmarking 86
8.2 GlobalData Consulting 86
8.3 Contact Us 87
8.4 Disclaimer 87
1.1 List of Tables
Table 1: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2015-2020 9
Table 2: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2021-2025 9
Table 3: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2020 11
Table 4: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2021-2025 11
Table 5: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2015-2020 13
Table 6: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2021-2025 13
Table 7: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2015-2020 15
Table 8: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2021-2025 15
Table 9: Neurosurgical Products Market, United States, Volume (Units), 2015-2020 17
Table 10: Neurosurgical Products Market, United States, Volume (Units), 2021-2025 17
Table 11: Dura Substitutes Market, United States, Volume (Units), 2015-2020 19
Table 12: Dura Substitutes Market, United States, Volume (Units), 2021-2025 19
Table 13: Neuroendoscopes Market, United States, Volume (Units), 2015-2020 21
Table 14: Neuroendoscopes Market, United States, Volume (Units), 2021-2025 21
Table 15: Neurosurgical Drills Market, United States, Volume (Units), 2015-2020 23
Table 16: Neurosurgical Drills Market, United States, Volume (Units), 2021-2025 23
Table 17: Neurosurgical Products Market, United States, Average Price ($), 2015-2020 24
Table 18: Neurosurgical Products Market, United States, Average Price ($), 2021-2025 25
Table 19: Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 26
Table 20: Neurosurgical Products Market, United States, Company Share by Revenue ($m), USD Constant, 2017 28
Table 21: Neurosurgical Products Market Pipeline Products 31
Table 22: Stryker Raises USD600 Million in Public Offering of 3.65% Notes Due 2028 32
Table 23: Integra LifeSciences Prices Public Offering of Shares for USD307 Million 34
Table 24: MRI Interventions Enters into Strategic Agreement with Voyager Therapeutics 36
Table 25: Shanghai Xianfeng Investment Management to Acquire Elliquence from Alan Ellman for USD77.1 Million 37
Table 26: Sobera Capital Acquires Equity Holdings in 12 Pharma Companies 38
Table 27: NeuroPace Raises USD74 Million in Equity Financing 40
Table 28: Myoscience Raises USD10 Million in Financing 41
Table 29: Alcyone Lifesciences Raises USD5 Million in Venture Financing 43
Table 30: MicroTransponder Raises USD11.6 Million in Venture Financing 44
Table 31: Total Number of Primary Research Participants, Neurology Devices Market, by Country 84
1.2 List of Figures
Figure 1: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2015-2025 8
Figure 2: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2025 10
Figure 3: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2015-2025 12
Figure 4: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2015-2025 14
Figure 5: Neurosurgical Products Market, United States, Volume (Units), 2015-2025 16
Figure 6: Dura Substitutes Market, United States, Volume (Units), 2015-2025 18
Figure 7: Neuroendoscopes Market, United States, Volume (Units), 2015-2025 20
Figure 8: Neurosurgical Drills Market, United States, Volume (Units), 2015-2025 22
Figure 9: Neurosurgical Products Market, United States, Company Share (%) 2017 27

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report